Stereochemistry and Chirality of Amino Acids
Hold up your two hands, palms facing you. They are mirror images. No amount of rotation lets you superimpose one on the other. Your left hand will never fit a right-handed glove, no matter how you turn it. Nineteen of the twenty standard amino acids are built the same way. Each has an alpha-carbon bonded to four different groups. This makes that carbon a "hand" in miniature. It is a stereocenter with two non-superimposable mirror-image forms. This single geometric fact — a carbon atom surrounded by four different substituents in tetrahedral array — is responsible for one of the deepest asymmetries in biology. Life on Earth uses almost exclusively one of the two possible mirror images. It uses this one form to build every protein, from insulin to actin to the ribozymes that made the first proteins possible. The reason this matters goes far beyond nomenclature. A protein is a folded chain. Folding depends on precise, reproducible local geometry at every residue. Suppose a chain were assembled from a random mixture of left-handed and right-handed amino acids. Then the backbone dihedral angles would scatter unpredictably. Secondary structures like the alpha helix and beta sheet could not form reliably. Enzymes could not build the reproducible three-dimensional active sites that make catalysis possible. Homochirality — one configuration, essentially without exception — is a precondition for the folding funnel. This funnel lets a polypeptide find its native structure. This is not a decorative fact about amino acids. It is a structural prerequisite for the entire protein-folding enterprise. Downstream, it is also a prerequisite for the stereospecificity of every enzyme active site. The same holds for every receptor-ligand interaction and every chiral drug's pharmacology. The big picture is this: tetrahedral carbon geometry generates chirality when four different groups are attached. This is an inescapable consequence of three-dimensional space. It is not a special or exotic case. Rather, it is the generic case for any singly-substituted alpha-carbon. Glycine is the single exception among the standard amino acids. Its side chain is a second hydrogen. This gives the alpha-carbon only three distinct groups, destroying the stereocenter. Every other proteinogenic amino acid is chiral. At each such carbon, two mirror-image possibilities exist. The biosynthetic machinery of essentially all known life selects and uses only one. This is the L-configuration in the older Fischer nomenclature. With one important exception, cysteine, this corresponds to the (S) configuration in the modern Cahn–Ingold–Prelog system. This article builds the geometric argument for why the alpha-carbon is (or is not) a stereocenter. It works through the mirror-image relationship in three dimensions, using Fischer projections as a bookkeeping tool. It quantifies what "one enantiomer" numerically means, via optical rotation and enantiomeric excess. It also surveys why L-amino acids won the evolutionary coin toss. This includes the sobering fact that the coin toss may not have been entirely fair. It sets up, without fully developing, the R/S and D/L labeling conventions. It also notes the existence of biologically important D-amino acids. Both of these topics deserve their own treatment.
- The alpha-carbon of an amino acid bears four groups — amino, carboxyl, R side chain, and H; when all four differ, it is a stereocenter.
- Glycine's R group is H, so its alpha-carbon has only three distinct substituents — it is not chiral, the sole exception among the 20 standard amino acids.
- Two amino acids sharing atom connectivity but differing at the stereocenter are enantiomers: identical physical properties except in chiral environments and in the direction they rotate plane-polarized light.
- Nearly all amino acids in proteins are the L-enantiomer (S-configuration for all but cysteine), a near-universal biological choice called homochirality.
- Enantiomeric purity is measured by optical rotation and expressed as enantiomeric excess (ee); a racemic mixture (50:50) shows zero net rotation.
- Homochirality is essential for reproducible protein secondary structure — a mixed-chirality chain cannot form regular helices or sheets.
- Key idea: a tetrahedral carbon with four different substituents cannot be superimposed on its mirror image, and evolution locked in only one of the two possible images for building proteins.
Where this lives today
Homochirality and stereocenter geometry are not museum pieces of 19th-century chemistry; they are load-bearing facts in modern biology and industry. In drug development, regulatory agencies (FDA, EMA) require that chiral drug candidates be evaluated as individual enantiomers where feasible, because one enantiomer may be therapeutically active while the other is inert or even harmful — the thalidomide tragedy of the late 1950s, in which one enantiomer was a safe sedative and the other proved teratogenic, is the canonical cautionary tale that reshaped pharmaceutical stereochemical practice worldwide. In peptide therapeutics, incorporating D-amino acids at strategic positions is a standard trick to make peptide drugs resistant to proteolytic degradation, since human proteases evolved to cleave only L-peptide bonds with stereospecific active sites; this exploits exactly the receptor-discrimination logic of the taste-receptor example above. In structural biology, the assumption of homochirality is built into every crystallographic refinement program and every prediction algorithm for protein structure (including modern deep-learning folding predictors), because the space of physically reasonable backbone dihedral angles (the Ramachandran map) is computed assuming L-amino acids throughout — a single D-residue substituted into a folded protein typically causes severe local strain, which is why naturally occurring D-amino acids in peptides (found in some antimicrobial peptides, cone snail toxins, and amphibian skin peptides) are installed post-translationally by dedicated peptide isomerases rather than by the ribosome itself, which reads the genetic code using only L-aminoacyl-tRNAs. In astrobiology and origin-of-life research, measuring small but statistically significant enantiomeric excesses of amino acids in carbonaceous meteorites (the Murchison meteorite being the most famous example) is an active line of evidence bearing on whether some component of biological homochirality was seeded from extraterrestrial chemistry via asymmetric photochemistry from circularly polarized starlight, later amplified by autocatalytic or crystallization-driven processes on the early Earth — reprising, on a planetary scale, the same ee-amplification logic worked through numerically above. Finally, in industrial biocatalysis, engineered racemases and epimerases are used deliberately to interconvert D- and L-amino acids for the synthesis of enantiopure fine chemicals, exploiting the same pyridoxal-phosphate Cα-deprotonation chemistry that alanine racemase uses in bacterial cell walls.
Ask the tutor: How do the Cahn–Ingold–Prelog priority rules actually assign R or S to an amino acid's alpha-carbon, and why does cysteine break the usual L = S pattern?
The physical picture — tetrahedral carbon as a molecular hand
Consider the generic amino acid skeleton: a central carbon (Cα) bonded to an amino group (–NH₂ or, at physiological pH, –NH₃⁺), a carboxyl group (–COOH or –COO⁻), a hydrogen atom, and a variable side chain, R. The four bonds from Cα point toward the corners of a tetrahedron, with ideal bond angles near 109.5°, set by sp³ hybridization. This geometry is not incidental — it is the same orbital hybridization that governs tetrahedral carbon and sp3 hybridization throughout organic chemistry, and it is what makes the chirality question purely geometric rather than electronic. The critical question is whether the four substituents around Cα are all different from one another. When R is anything other than H — that is, for every amino acid except glycine — the four groups (NH₃⁺, COO⁻, R, H) are four distinct chemical entities. A tetrahedral center with four different substituents has exactly two possible spatial arrangements, and these two arrangements are non-superimposable mirror images of each other: enantiomers. You can convince yourself of the non-superimposability by attempting, mentally or with a physical model, to rotate one arrangement onto the other; no rotation in three-dimensional space accomplishes it, because a mirror reflection is not a rotation. This is exactly analogous to why your left and right hands cannot be superimposed by any rotation, only by reflection — hence the term "chirality," from the Greek cheir, hand. Glycine is the exception that proves the rule. Its side chain is a second hydrogen atom, so Cα is bonded to NH₃⁺, COO⁻, H, and H — two identical substituents. A tetrahedral carbon with two identical groups has a plane of internal symmetry (through the unique groups) that maps the molecule onto its own mirror image; glycine is achiral, and its "two enantiomers" are actually the same molecule viewed from different angles. This makes glycine structurally unique among the 20 standard amino acids: it can adopt backbone dihedral angles inaccessible to any other residue, one reason glycine is conserved at tight turns in protein structures. A useful bookkeeping device for comparing configurations is the Fischer projection, in which the carbon chain is drawn vertically with horizontal bonds coming toward the viewer (out of the page) and vertical bonds going away from the viewer (into the page). By convention, the amino acid is drawn with the carboxyl group at the top, the side chain at the bottom, and the amino group and hydrogen on the horizontal arms. If the amino group points to the left, the molecule is designated L (Latin laevus, left); if to the right, D (dexter, right). This convention is purely a naming device tied to a specific drawn orientation — it says nothing directly about the sign of optical rotation, and the connection to the modern (R)/(S) system requires assigning Cahn–Ingold–Prelog priorities, a topic developed fully in its own treatment of D/L and R/S nomenclature.
The core ideas — chirality, optical activity, and enantiomeric excess
The number of stereocenters and the number of possible stereoisomers are related by a simple counting rule for a molecule with independent tetrahedral stereocenters:
where:
- — the maximum number of distinct stereoisomers,
- — the number of independent stereocenters in the molecule.
For a standard amino acid with a single stereocenter at Cα (), this gives : the L- and D-forms, and no others. Threonine and isoleucine are exceptions worth flagging (and returning to in the article on nonstandard and modified amino acids): each has a second stereocenter in its side chain, so and there are stereoisomers — two pairs of enantiomers, related to each other as diastereomers, which (unlike enantiomers) have genuinely different physical properties such as melting point and solubility. Optical activity is the experimental signature that distinguishes enantiomers, since they are otherwise identical in achiral environments (boiling point, solubility in achiral solvents, IR/NMR spectra in achiral conditions are the same). The observed rotation of plane-polarized light passing through a sample is:
where:
- — observed rotation in degrees,
- — specific rotation at temperature using the sodium D-line (589 nm), a constant characteristic of the pure enantiomer, in units of degrees·mL·g⁻¹·dm⁻¹,
- — concentration in g/mL,
- — path length in dm.
Enantiomers have specific rotations equal in magnitude and opposite in sign; a 50:50 mixture (racemate) shows because the rotations exactly cancel. The purity of a non-racemic sample is quantified by the enantiomeric excess:
where:
- , — the concentrations (or mole fractions) of each enantiomer.
Enantiomeric excess connects directly back to optical rotation, since for an ideal mixture the observed specific rotation scales linearly with ee:
where:
- — the specific rotation measured for the actual (possibly impure) sample,
- — the specific rotation of the enantiomerically pure compound,
- ee — the enantiomeric excess as a percentage.
The reading of these equations together is that optical rotation is a linear reporter of enantiomeric composition: it is exactly zero at the racemate, rises linearly (in the ideal case) as one enantiomer comes to dominate, and reaches only at 100% ee. This linearity is what makes polarimetry a quantitative assay for stereochemical purity, both in a teaching laboratory and in pharmaceutical quality control.
Goal. Show rigorously, using nothing but the geometry of a tetrahedron, that a carbon bonded to four distinct groups A, B, C, D has exactly two spatial arrangements, and that these two arrangements cannot be brought into coincidence by any rotation — only by reflection.
Step 1 — Set up the tetrahedral vertices. Place the central carbon at the origin. The four bonds point toward the four vertices of a regular tetrahedron, which can be taken (up to scale) at coordinates , , , . Any assignment of the four distinct groups A, B, C, D to these four vertices defines one specific stereoisomer.
Step 2 — Count the distinguishable assignments. There are ways to assign four labeled groups to four labeled vertices. But the tetrahedron itself has a rotation group of order 12 (the alternating group : identity, 8 rotations by ±120° about the four vertex–face axes, and 3 rotations by 180° about the three edge-midpoint axes). Two vertex-assignments related by one of these 12 rotations represent the same molecule viewed from a different orientation in space, not a different molecule. Dividing out the rotational redundancy:
So there are exactly 2 geometrically distinct arrangements — consistent with the general counting rule at .
Step 3 — Show the two arrangements are mirror images. Take one assignment (call it arrangement I) and apply an improper symmetry operation — a reflection through a plane containing the carbon, e.g., , leaving fixed. This reflection maps the four vertices to a new set of positions occupied by A, B, C, D in an order that is not obtainable from arrangement I by any of the 12 proper rotations found in Step 2 (reflections are not elements of the rotation group ; they belong instead to the full symmetry group of the tetrahedron, order 24, which includes 12 improper operations). Call this reflected arrangement II. By construction, I and II have identical bond lengths, angles, and connectivity — they are the same constitutional molecule — but they are related by an operation (reflection) that is outside the rotation group.
Step 4 — Prove non-superimposability. Suppose, for contradiction, that some rotation in the 12-element rotation group carries arrangement I exactly onto arrangement II. Then the reflection that produced II could be written as acting trivially — but this would mean a rotation equals a reflection composed with the identity, i.e., a proper rotation would have to reproduce the effect of an improper operation. This is impossible: rotations preserve orientation (they have determinant acting on the coordinate frame), while reflections reverse it (determinant ). No sequence of determinant- operations can equal a determinant- operation. Hence no rotation superimposes I onto II: arrangement I and arrangement II are genuinely different, non-superimposable objects — enantiomers — even though every bond length and bond angle in them is identical.
Conclusion. A tetrahedral carbon with four different groups admits exactly 2 stereoisomers (Step 2), and these two are related only by reflection, never by rotation (Steps 3–4). This is precisely the mathematical content of "chirality": geometric distinctness that survives all rigid-body motion and is undone only by reflection. Applied to Cα of any amino acid other than glycine, with A = NH₃⁺, B = COO⁻, C = R, D = H all distinct, the theorem guarantees exactly two enantiomers, L and D, related by reflection alone.
Go deeper · Derivation B · 1 minEnantiomeric excess from specific rotation: a worked reconstruction
Goal. Derive the linear relation between observed specific rotation and enantiomeric excess directly from the additivity of optical rotation contributions, and use it to back out a sample's composition from a measured rotation.
Step 1 — Additivity of rotation. Optical rotation, to an excellent approximation for dilute, non-interacting solute molecules, is an additive property: each enantiomer molecule contributes independently to the total rotation, with the (R)-form contributing per unit concentration and the (S)-form contributing per unit concentration (or vice versa, by definition of which one is dextrorotatory). If a sample has concentration of the R-enantiomer and of the S-enantiomer, the net specific rotation is a concentration-weighted average:
Step 2 — Identify the ee term. The bracketed fraction is, by definition, exactly the enantiomeric excess (as a fraction rather than a percentage):
so directly:
which is the relation asserted above, now derived from first principles of additive contributions rather than merely asserted.
Step 3 — Invert to extract composition from a measurement. Given an experimentally measured and the tabulated for the enantiomerically pure compound, solve for ee:
Then convert ee into individual mole fractions using (normalized total) together with , giving two equations in two unknowns:
Step 4 — Numerical check with asymmetric, realistic numbers. Suppose a sample of alanine has a measured specific rotation of under conditions where pure L-alanine (which is dextrorotatory, -configuration) has (a literature-consistent order-of-magnitude value for amino acid specific rotations). Then:
so ee ≈ 38.6%, and the mole fractions are:
This sample is 69.3% of the enantiomer defined as dextrorotatory-pure (here, L/S-alanine) and 30.7% of its mirror image — far from racemic (which would give ) but also far from enantiopure (which would give ). The check that confirms internal consistency, and setting recovers , the racemic limit, as it must.
Worked examples
Example 1 — Foundational: identifying the stereocenter and its substituents for alanine. Alanine's Cα carries four groups: –NH₃⁺ (at physiological pH), –COO⁻, –CH₃ (the side chain), and –H. All four are constitutionally distinct — nitrogen-bearing group, oxygen-bearing group, a carbon substituent, and a bare hydrogen — so by the theorem proved above, Cα is a genuine stereocenter and alanine exists as two enantiomers, L-alanine and D-alanine. Ribosomal protein synthesis incorporates essentially only L-alanine; D-alanine appears almost exclusively in bacterial cell-wall peptidoglycan, synthesized post-translationally by a dedicated racemase, alanine racemase, which uses a pyridoxal-5′-phosphate cofactor to abstract and reprotonate the Cα–H, scrambling the stereocenter enzymatically. This example fixes the vocabulary: "stereocenter," "enantiomer," "L vs. D" as a spatial-drawing convention, and demonstrates why the same skeleton can, in different biological contexts, appear in either configuration.
Example 2 — Applied: distinguishing enantiomers by taste, an everyday chiral bioassay. L-asparagine tastes bitter to most people, while D-asparagine tastes sweet — a classic demonstration that a biological receptor (the sweet-taste GPCR, itself built from L-amino acids and therefore chiral in its binding pocket) can discriminate perfectly between mirror-image ligands even though the two ligands have identical achiral physical properties (identical melting points, identical solubility in ethanol, identical mass spectra). The mechanistic reason is a three-point-contact model: a chiral receptor pocket makes at least three spatially oriented contacts with a chiral ligand (hydrogen bond, ionic interaction, hydrophobic pocket, positioned asymmetrically), and only one enantiomer can simultaneously satisfy all three contacts in the correct geometric register — the mirror-image ligand, presented to the same asymmetric pocket, necessarily fails at least one contact or engages a different set of residues, changing the downstream signal. This is the general mechanism by which every chiral biological receptor — taste receptors, olfactory receptors, drug targets, enzyme active sites — discriminates enantiomers that no achiral instrument (boiling point, solubility, ordinary polarimeter-free spectroscopy) could tell apart.
Example 3 — Exam/competition level: quantifying near-total homochirality with an ee argument, and estimating the energetic argument against a coincidence. Suppose a hypothetical prebiotic "amino acid pool" that seeded early biochemistry had only a small initial enantiomeric excess of 2% ee (a value in the range reported for some amino acids recovered from carbonaceous meteorites, attributed to circularly-polarized starlight or parity-violating weak-interaction asymmetries acting on presolar material). Modern proteins show, for practical purposes, ee ≈ 99.9%+ (L-amino acids are, within experimental detection limits — occasional post-translational epimerization aside — essentially the only species used in ribosomal translation). The question: is it plausible that ribosomal machinery itself discriminates so sharply, or must amplification have occurred before or during the origin of the genetic code? Work the energetics. Enantiomers by definition have identical Gibbs free energy in an achiral environment — there is no thermodynamic driving force in bulk solution that would spontaneously enrich one enantiomer over the other; racemization is entropically favored (ΔS > 0 for mixing) and the free-energy difference between a racemate and a pure enantiomer, from the entropy of mixing alone, is:
where:
- — gas constant, ,
- — temperature in kelvin,
- — mole fractions of each enantiomer.
At , :
This negative value (favoring the racemate, i.e., mixing is spontaneous relative to either pure enantiomer) is the entire thermodynamic story in an achiral environment — there is no bulk free-energy preference for L over D of any comparable size hiding in ordinary chemistry. Amplifying 2% ee to >99.9% ee therefore cannot happen by any equilibrium process in an achiral medium; it requires a kinetic, autocatalytic, symmetry-breaking mechanism (such as the Soai reaction, an experimentally realized autocatalytic amplification of small initial ee to near-total ee) or a template/selection process operating once self-replication and translation began — exactly the puzzle addressed by origin-of-life research into homochirality, and a reminder that today's near-total biological homochirality reflects historical selection locked in early and conserved ever since, not a per-reaction thermodynamic preference recomputed by every cell.
Limiting cases, scope & common traps
| Situation | What happens | Why |
|---|---|---|
| Glycine (R = H) | No stereocenter; achiral | Two identical H substituents create an internal mirror plane |
| Any other standard amino acid | Exactly 2 enantiomers (L, D) | Cα has 4 distinct groups: NH₃⁺, COO⁻, R, H |
| Threonine, isoleucine | 4 stereoisomers (2 pairs of enantiomers) | A second stereocenter exists in the side chain (, so ) |
| Racemic mixture (50:50) | Zero net optical rotation | Equal and opposite contributions cancel exactly |
| ee → 0 | Racemic limit recovered from the derived linear relation | |
| ee → 100% | Enantiopure limit recovered | |
| Achiral solvent, achiral detector | Enantiomers indistinguishable | Only chiral probes (polarized light, chiral receptors) discriminate them |
| Bacterial peptidoglycan, some peptide antibiotics | D-amino acids used deliberately | Enzymatic racemases/epimerases act after or during synthesis, resisting protease attack |
The chemist behind it
The modern framework for amino acid stereochemistry rests on foundations laid by Louis Pasteur, who in 1848 first physically separated crystals of sodium ammonium tartrate into two mirror-image forms under a microscope and showed that solutions of the separately-crystallized forms rotated polarized light in opposite directions — the first demonstration that molecular chirality has a measurable macroscopic consequence. Pasteur's tartrate work established that "handedness" is a real physical property of molecules, not merely an abstraction of drawn structures, decades before the tetrahedral carbon model existed to explain why. That explanation came from Jacobus Henricus van 't Hoff and, independently, Joseph Achille Le Bel, who in 1874 proposed that the four bonds of carbon are directed toward the vertices of a tetrahedron — a bold structural hypothesis at the time, since no direct method existed to "see" molecular geometry, but one that correctly predicted the existence and count of stereoisomers for compounds with one, two, or more stereocenters, exactly the counting argument used throughout this article. Van 't Hoff went on to a rich career in physical chemistry (including foundational work on reaction rates and osmotic pressure, for which he won the first Nobel Prize in Chemistry in 1901), but it is the tetrahedral carbon proposal, made while he was not yet 22 years old, that underlies every statement in this article about why Cα is or is not a stereocenter.
Origins · 1 minJacobus Henricus van 't Hoff and how this was discovered
Van 't Hoff proposed the tetrahedral carbon atom in 1874, providing the first structural explanation for optical isomerism observed by Pasteur decades earlier. He later founded much of physical chemistry — reaction kinetics, chemical equilibrium, and the theory of dilute solutions and osmotic pressure — and received the first Nobel Prize in Chemistry (1901) largely for that later body of work, though the tetrahedral carbon hypothesis remains his most conceptually foundational single idea for organic and biological stereochemistry.
Is glycine the only achiral proteinogenic amino acid, or are there others?
Among the 20 standard amino acids, glycine is the sole achiral one, because it is the only case where the side chain R is itself a hydrogen atom, giving Cα only three distinct substituents (NH₃⁺, COO⁻, and two H's) rather than four. Every other standard amino acid has a side chain distinct from H, NH₃⁺, and COO⁻, guaranteeing four different groups and therefore a genuine stereocenter. Note that some amino acids (threonine, isoleucine) have a second stereocenter located in the side chain rather than at Cα, so they are chiral for two independent reasons simultaneously, but this does not change the fact that glycine remains the unique achiral case overall.
Do L-amino acids and D-amino acids have different melting points or solubilities?
No — as pure, isolated enantiomers in an achiral environment, L- and D-forms of the same amino acid have identical melting points, identical solubility in ordinary (achiral) solvents, identical density, and identical standard spectroscopic signatures (IR, mass spec, and ordinary NMR). The only difference detectable without a chiral probe is the sign of optical rotation. A racemic mixture of the two, however, can have a different melting point than either pure enantiomer, because the crystal packing of a 1:1 racemic solid is often a distinct crystalline phase (a "racemic compound") with its own lattice energy — this is a property of the mixture's crystal structure, not evidence that the individual enantiomers differ.
Why do almost all organisms use L-amino acids instead of D-amino acids?
This is one of biology's open deep questions, generally discussed under "biological homochirality." There is no intrinsic thermodynamic reason favoring L over D — the two enantiomers have identical Gibbs free energy in an achiral environment, so no equilibrium process in ordinary chemistry would spontaneously enrich one over the other. The leading explanations invoke a small initial statistical or physical bias (from circularly polarized astronomical radiation, parity-violating weak-interaction effects, or stochastic local fluctuation) that was then locked in and amplified by an autocatalytic or self-replicating chemical system early in the origin of life, after which the choice became fixed because the genetic code and ribosomal machinery co-evolved around a single configuration and any switch would now be catastrophically disruptive to existing folded, functional proteins.
Are there any D-amino acids in biology at all, or is the L-rule absolute?
D-amino acids do occur in biology, but they are made by dedicated post-translational enzymes (racemases, epimerases) rather than being incorporated directly by the ribosome, which reads only L-aminoacyl-tRNAs during translation. D-alanine and D-glutamate are structural components of bacterial peptidoglycan cell walls, conferring resistance to most host proteases (which are stereospecific for L-peptide bonds). D-amino acids are also found in some peptide antibiotics (gramicidin), cone snail venom peptides, and amphibian skin defensive peptides, generally installed by a peptide isomerase acting on an already-synthesized L-peptide. None of this contradicts the rule that ribosomal protein synthesis itself uses exclusively L-amino acids; it reflects specialized enzymatic modification occurring afterward.
How does a Fischer projection let you assign L or D without building a 3D model?
Draw the amino acid vertically with the most oxidized carbon (the carboxyl group) at the top and the side chain at the bottom, following the historical convention that horizontal bonds point toward the viewer and vertical bonds point away. If the amino group (–NH₃⁺) appears on the left horizontal arm, the amino acid is L; if it appears on the right, it is D. This is purely a 2D bookkeeping convention tied to a specific drawing orientation — rotating the physical 3D molecule doesn't change its actual configuration, but redrawing a Fischer projection incorrectly (e.g., rotating it 90° in the plane of the page, which inverts the apparent front/back assignment) can create the illusion of a different configuration. This fragility is exactly why the more rigorous, structure-based Cahn–Ingold–Prelog (R/S) system was developed later.
If enantiomers are chemically "identical" except for chirality, why does the FDA care so much about which one is in a drug?
Because the human body is built almost entirely from L-amino acids, essentially every protein target a drug might bind — enzymes, receptors, transporters — is itself chiral, with an asymmetric binding pocket. Two enantiomers of a drug candidate can therefore have wildly different biological activity even though they are chemically "the same substance" by achiral measures, exactly as in the three-point-contact taste receptor example. One enantiomer might be the intended therapeutic agent while its mirror image is inactive, less potent, or in rare tragic cases (thalidomide) actively harmful. Because ordinary achiral synthesis and quality-control methods cannot distinguish these possibilities, regulators require explicit enantiomeric characterization and, where relevant, testing of each enantiomer's pharmacology and toxicology separately.
Does the counting rule 2^n ever overcount the actual number of distinct stereoisomers?
Yes, when a molecule has an internal symmetry that makes two "different" stereocenter assignments actually identical — the classic case is a meso compound, where a molecule has two stereocenters but also an internal mirror plane relating them, so two of the four naively counted stereoisomers collapse into one achiral structure. Among the standard 20 amino acids this situation does not arise (their multiple stereocenters, as in threonine and isoleucine, are not related by an internal symmetry element), so gives the correct count of 4 stereoisomers for those two amino acids; the meso caveat is worth remembering as a general rule for stereochemistry, even though it doesn't apply within this specific set of molecules.